Gene · 6314
Papers1,627
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,627
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potpourri of retinopathies in rare eye disease - A case series. | Indian J Ophthalmol | 2022 | 35791168 | PubTator, text mining | PubMed |
| Molecular insights into the interaction of CAG trinucleotide RNA repeats with nucleolin and its implication in polyglutamine diseases. | Nucleic Acids Res | 2022 | 35776134 | PubTator, text mining | PubMed |
| Functional validation of novel variants in B4GALNT1 associated with early-onset complex hereditary spastic paraplegia with impaired ganglioside synthesis. | Am J Med Genet A | 2022 | 35775650 | PubTator, text mining | PubMed |
| Vulnerability of Human Cerebellar Neurons to Degeneration in Ataxia-Causing Channelopathies. | Front Syst Neurosci | 2022 | 35757096 | PubTator, text mining | PubMed |
| Radiological hints for differentiation of cerebellar multiple system atrophy from spinocerebellar ataxia. | Sci Rep | 2022 | 35732792 | PubTator, text mining | PubMed |
| EagleC: A deep-learning framework for detecting a full range of structural variations from bulk and single-cell contact maps. | Sci Adv | 2022 | 35704579 | PubTator, text mining | PubMed |
| Key Modulators of the Stress Granule Response TIA1, TDP-43, and G3BP1 Are Altered by Polyglutamine-Expanded ATXN7. | Mol Neurobiol | 2022 | 35689166 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Cerebellar Abnormalities on Proton MR Spectroscopy and Imaging in Patients With Gluten Ataxia: A Pilot Study. | Front Hum Neurosci | 2022 | 35655925 | PubTator, text mining | PubMed |
| Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool. | Biomolecules | 2022 | 35625579 | PubTator, text mining | PubMed |
| Diversity and Biotechnological Potential of Marine Actinomycetes from India. | Indian J Microbiol | 2022 | 35601673 | PubTator, text mining | PubMed |
| Profiling the Genome-Wide Landscape of Short Tandem Repeats by Long-Read Sequencing. | Front Genet | 2022 | 35601492 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Interplay Define Disease Onset and Severity in Repeat Diseases. | Front Aging Neurosci | 2022 | 35592702 | PubTator, text mining | PubMed |
| Clinical Features and Genetic Spectrum of Patients With Clinically Suspected Hereditary Progressive Spastic Paraplegia. | Front Neurol | 2022 | 35572931 | PubTator, text mining | PubMed |
| Clinical and genetic spectrums of 413 North African families with inherited retinal dystrophies and optic neuropathies. | Orphanet J Rare Dis | 2022 | 35551639 | PubTator, text mining | PubMed |
| Are ATXN2 variants modifying our understanding about neural pathogenesis, phenotypes, and diagnostic? | Neural Regen Res | 2022 | 35535893 | PubTator, text mining | PubMed |
| Cross-species genetic screens identify transglutaminase 5 as a regulator of polyglutamine-expanded ataxin-1. | J Clin Invest | 2022 | 35499073 | PubTator, text mining | PubMed |
| A Severe Dementia Syndrome Caused by Intron Retention and Cryptic Splice Site Activation in STUB1 and Exacerbated by TBP Repeat Expansions. | Front Mol Neurosci | 2022 | 35493319 | PubTator, text mining | PubMed |
| Calpains as novel players in the molecular pathogenesis of spinocerebellar ataxia type 17. | Cell Mol Life Sci | 2022 | 35482253 | PubTator, text mining | PubMed |
| Cognitive Dysfunction in Repeat Expansion Diseases: A Review. | Front Aging Neurosci | 2022 | 35478698 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6314/papers?page=13